Search
25/01/2026
In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis
Mallén, A, Rotllan, N, Griñán, R, Varela, C, Bertolino, E, Paloschi, V, Maegdefessel, L, Escolà-Gil, JC, Aran, JM, Sbraga, F, Blasco-Lucas, A, Torras, J, Navarro, E, Hueso, M. In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2026; 330(1)DOI:10.1152/ajpcell.00242.2025. PMID:41289597. IF:4.700(Q1/1D).
25/01/2026
Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial
Puig-Davi, A, Moreu-Valls, A, Aracil-Bolaños, I, Fernandez-Cocaño, A, Rodríguez-Antigüedad, J, Kulisevsky, G, Horta-Barba, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-31833-1. PMID:41582160. IF:3.900(Q1/2D).
22/01/2026
IL-6 in the spotlight: From cardiovascular pathophysiology to therapy
Preda, A, Tirandi, A, Leo, G, Di Vece, D, Vilahur, G, Bonaventura, A, Osto, E, Ministrini, S, Kraler, S, Kleinbogard, P, Camici, G, Carbone, F, Montecucco, F, Liberale, L. IL-6 in the spotlight: From cardiovascular pathophysiology to therapy. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70161. PMID:41340186. IF:3.600(Q1/2D).
22/01/2026
HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C
Padro, T, Muñoz-García, N, Fanlo-Maresma, M, Esteve-Luque, V, Cabré-Fernandez, P, Vilahur, G, Riera-Mestre, A, Badimon, L, Pinto, X. HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70159. PMID:41413729. IF:3.600(Q1/2D).
20/01/2026
Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024
Formigo, GMS, Mazorra, Z, Olexen, C, Menéndez, T, Hadi, LA, Handgretinger, R, Hernandez, AAB, El Najjar, I, Coukos, G, Sabzevari, H, Bollard, C, Couriel, D, Wald, D, Hamieh, M, Briones, J, Al Kaabi, F, Ventura-Carmenate, Y. Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024. Frontiers in Immunology. 2026; 16DOI:10.3389/fimmu.2025.1650023. PMID:41641269. IF:5.900(Q1/2D).
20/01/2026
Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives
Gonzalez-Cucharero, C, Vilahur, G, Saura, M, Hinojar, R, Zamorano, JL, Zaragoza, C. Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70138. PMID:41131691. IF:3.600(Q1/2D).